It was reported that the patient passed away on (b)(6) 2021 due to septic shock, bacteremia, cardiogenic shock and acidosis respiratory failure shock.Whether the outcome was device or therapy related was not provided.It is unknown if the device will be returned for evaluation.No additional information provided.
|
Manufacturer's investigation conclusion: a direct correlation between heartmate 3 lvas, serial number (b)(6) , and the reported events could not be conclusively determined through this evaluation.The patient expired on (b)(6) 2021 due to septic shock, bacteremia, cardiogenic shock, and acidosis respiratory failure shock.The heartmate 3 lvad, serial number (b)(6) , was not returned for analysis.The heartmate 3 lvas ifu, is currently available.Section 1 ¿introduction¿ of this document lists sepsis, respiratory failure, and death as adverse events that may be associated with the use of the heartmate 3 lvas.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The relevant sections of the device history records for the percutaneous lead were also reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on (b)(6) 2021.No further information was provided.The manufacturer is closing the file on this event.
|